Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) shared new and updated results from its RESET clinical development program at major scientific conferences, presenting data on the first 10 patients treated …
Cabaletta Bio Reveals Promising Clinical Data for Autoimmune Therapy Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced the successful completion of a full study on its localized pain management product, Probudur™, conducted in partnership with the U.S. Army …
Virpax Pharmaceuticals Advances Pain Management with Promising Probudur Study Results Read More
EXTON, PA — Innovative Solutions & Support, Inc. (Nasdaq: ISSC) posted robust fiscal first quarter results, reporting $16.0 million in revenue, a 71.6% increase compared to the prior year. The growth …
IS&S Reports Strong Fiscal Q1 2025 Results with 71.6% Revenue Growth Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced the completion of dosing in the Phase 2 portion of its ArMaDa clinical trial for OCU410. This novel multifunctional modifier gene therapy …
Breakthrough Gene Therapy OCU410 Could Save Millions from Vision Loss – Phase 2 Milestone Achieved! Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug that acts as a covalent inhibitor of two key immune signaling kinases, ITK …
Aclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 Inhibitor Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the expansion of SELVA, its Phase 3 clinical trial of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), to include children as young …
Palvella Therapeutics Expands Phase 3 Trial to Younger Patients Read More
MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP) announced robust financial results for the second quarter of fiscal 2025, showcasing continued growth in revenue and adoption of new technologies. The company reported …
Cantaloupe Reports Strong Q2 Results, Launches Innovative Solutions Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) recently announced the issuance of Restricted Stock Units (RSUs) as part of inducement awards granted to two newly hired non-executive employees. The awards cover …
Neuronetics Announces Stock Awards to New Employees Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More
MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP) has introduced Cantaloupe Capital, a new financing platform developed in partnership with Fundbox, to provide small business operators in the self-service retail industry with …
Cantaloupe, Inc. Launches Cantaloupe Capital to Support Small Business Growth Read More